EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a vaccine based on mRNA assembly of PEDV virus-like particle

Mengdi Yang, Yongxiang Zhao, Weilu Guo, Lizhong Wang, Xu Song, Xinmei Geng, Shiyu Liu, Hongqi Shang, Mi Hu, Shanshan Yang, Yunchuan Li, Min Sun und 4 weitere

Journal of Virology · 2026

DOI: 10.1128/jvi.02060-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Mengdi Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Minis…. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Coronavirus Infections, Viral Vaccines, Vaccines, Virus-Like Particle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Funding Program for Excellent Postdoctoral Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine epidemic diarrhea virus (PEDV) represents a highly contagious enteropathogenic coronavirus affecting swine. This virus elicits acute diarrhea in neonatal nursing piglets, with mortality approaching 100%, and, thus, imposes enormous economic burdens on the worldwide pork industry. Therefore, developing safe and effective vaccines remains a top priority for controlling PEDV. Here, we constructed a lipid-nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccine. This vaccine encodes the four major structural proteins of PEDV: spike (S), membrane (M), envelope (E), and nucleocapsid (N), which self-assemble into virus-like particle (VLP). Compared with a PEDV S-only mRNA vaccine and a commercial PEDV/transmissible gastroenteritis virus (TGEV) bivalent inactivated vaccine in a mouse model, this VLP mRNA vaccine induced significantly higher levels of IgG, mucosal IgA, and neutralizing antibodies. It also enhanced the lymphocyte proliferation index and expanded the populations of T and B cells. Subsequent evaluations in sows showed that the VLP mRNA vaccine elicited robust PEDV-specific immune responses in vivo . Furthermore, piglets that suckled colostrum from these vaccinated sows gained protection against challenge with a virulent PEDV strain. These protected piglets exhibited lower diarrhea scores, reduced viral shedding, less severe intestinal lesions, and decreased mortality. Collectively, these findings demonstrate that the developed PEDV VLP mRNA platform constitutes a highly promising strategy for preventing PEDV infections. IMPORTANCE PEDV-induced watery diarrhea in neonatal piglets remains a major threat to the global swine industry, while current commercial vaccines are predominantly inactivated formulations or S-only subunit vaccines, whose efficacy and broad-spectrum protection continue to be limited. We, therefore, incorporated the four PEDV structural proteins (S-M-E-N) into a LNP mRNA vaccine that self-assembles into VLPs in vivo . In mice, the mRNA-VLP platform elicited significantly higher systemic IgG, mucosal IgA, and neutralizing antibody titers than an S-only mRNA control or a commercial PEDV/TGEV inactivated vaccine, while expanding both T- and B-cell populations. Maternal immunization of pregnant sows converted these responses into potent systemic immunity that protected suckling piglets against virulent challenge, as evidenced by markedly reduced diarrhea scores, intestinal lesions, viral shedding, and mortality. Collectively, the developed PEDV mRNA-VLP platform offers a highly promising strategy for preventing PEDV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine epidemic diarrhea virusCoronavirus InfectionsViral VaccinesVaccines, Virus-Like ParticleRNA, MessengerSwine DiseasesAnimalsSwineAntibodies, ViralMiceAntibodies, NeutralizingFemaleVaccine DevelopmentNanovaccinesNanoparticlesImmunoglobulin AMice, Inbred BALB C

Stichwörter der Autor:innen

PEDVimmunogenicitymRNA vaccinevirus-like particle

Substanzen

Antibodies, ViralViral VaccinesVaccines, Virus-Like ParticleRNA, MessengerAntibodies, NeutralizingNanovaccinesImmunoglobulin A

Autor:innen und Institutionen

  • Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture; Jiangsu Key Laboratory for Food Quality and Safety…
  • College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
  • Taizhou Polytechnic College, Taizhou, China.
  • Suzhou Huiliao Biomedical Technology Co., Ltd., Suzhou, China.
  • Suzhou Medical College, Soochow University, Suzhou, China.
  • Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China.

ORCID-Profile: Lixiang Zhao, Bin Li, Baochao Fan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • National Science Foundation of Jiangsu Province
  • Jiangsu Agricultural Science and Technology Innovation Fund
  • Jiangsu Academy of Agricultural Science Scientific Research Fund Project
  • Jiangsu Provincial Key Construction Laboratory of Probiotics Preparation Open Project

Zitieren

APA

Yang, M., Zhao, Y., Guo, W., Wang, L., Song, X., Geng, X., Liu, S., Shang, H., Hu, M., Yang, S., Li, Y., Sun, M., Zhao, L., Zhong, T., Li, B., & Fan, B. (2026). Development of a vaccine based on mRNA assembly of PEDV virus-like particle. Journal of Virology. https://doi.org/10.1128/jvi.02060-25

Vancouver

Yang M, Zhao Y, Guo W, Wang L, Song X, Geng X, et al. Development of a vaccine based on mRNA assembly of PEDV virus-like particle. Journal of Virology. 2026. doi:10.1128/jvi.02060-25

BibTeX
@article{Yang2026,
  author = {Yang, Mengdi and Zhao, Yongxiang and Guo, Weilu and Wang, Lizhong and Song, Xu and Geng, Xinmei and Liu, Shiyu and Shang, Hongqi and Hu, Mi and Yang, Shanshan and Li, Yunchuan and Sun, Min and Zhao, Lixiang and Zhong, Tianyi and Li, Bin and Fan, Baochao},
  title = {Development of a vaccine based on mRNA assembly of PEDV virus-like particle},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.02060-25}
}
Kostenlos starten →